Compound 2187
Identifiers
- Canonical SMILES:
Oc1ccc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c2ccccc12
- IUPAC name:
4-[2-(4-hydroxynaphthalen-1-yl)diazen-1-yl]-N-(pyridin-2-yl)benzene-1-sulfonamide
- InChi:
InChI=1S/C21H16N4O3S/c26-20-13-12-19(17-5-1-2-6-18(17)20)24-23-15-8-10-16(11-9-15)29(27,28)25-21-7-3-4-14-22-21/h1-14,26H,(H,22,25)
- InChiKey:
BKKIAVKYDURMCC-UHFFFAOYSA-N
External links
![]() 136240256 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 404.09 g/mol | |||
HBA | 7 | |||
HBD | 2 | |||
HBA + HBD | 9 | |||
AlogP | 4.93 | |||
TPSA | 101.21 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.7705 | Sulfasalazine | DB00795 | |
0.7684 | Sulfapyridine | DB00891 | |
0.5690 | Sulfaquinoxaline | DB11464 | |
0.5631 | Sulfadiazine | DB00359 | |
0.5487 | Sulfameter | DB06821 | |
0.5321 | Sulfaperin | DB13320 | |
0.5318 | Sulfachlorpyridazine | DB11461 | |
0.5191 | Sulfamethoxypyridazine | DB13773 | |
0.5128 | Sulfamethazine | DB01582 | |
0.5110 | ABT-751 | DB12254 | |
0.5074 | Sulfaethoxypyridazine | DB11462 | |
0.4962 | Chlorsulfaquinoxaline | DB12921 | |
0.4957 | Sulfamerazine | DB01581 | |
0.4776 | Sulfametopyrazine | DB00664 | |
0.4762 | Sulfabromomethazine | DB11547 |